VANESSA RAMSEY: Open Payments
NPI 1003678269 · KAUFMAN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,127 in 111 payments from 24 companies in 2025. Trend: 2023 $0 · 2024 $1,222 · 2025 $2,127
Food & beverage: $2,127
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $412 |
| AstraZeneca Pharmaceuticals LP | 13 | $261 |
| PFIZER INC. | 7 | $171 |
| Novo Nordisk Inc | 10 | $153 |
| Corcept Therapeutics | 4 | $151 |
| Lilly USA, LLC | 8 | $140 |
| SANOFI-AVENTIS U.S. LLC | 5 | $129 |
| Astellas Pharma US Inc | 6 | $107 |
| Antares Pharma, Inc. | 5 | $90 |
| GlaxoSmithKline, LLC. | 5 | $85 |
Products named: VRAYLAR, AIRSUPRA, Korlym, TZIELD, Veozah, XYOSTED, Ozempic, MOUNJARO.
Industry payments across TX — which companies pay providers there.
